Die Zhang1, Shen Yang, Chunhao Yang, Guozhang Jin, Xuechu Zhen. 1. State Key Laboratory of Drug Research, Department of Neuropharmacology, Shanghai Institute of Material Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Pudong, Shanghai, China.
Abstract
RATIONALE: Sex differences in cocaine abuse have been well documented. However, the underlying mechanism remains unclear. OBJECTIVES: To explore the potential role of ovarian hormones in the regulation of dopamine (DA) neuron firing activity in ventral tegmental area (VTA) induced by acute cocaine in intact female or ovariectomized (OVX) rats. RESULTS: The basal firing activity of VTA DA neurons was changed in a manner phase-locked to the estrous cycle: being highest in estrus and lowest in proestrus. Acute cocaine produced greater inhibition (P < 0.05) on the firing of VTA DA neurons during proestrus than during estrus. The inhibitory effect was completely blocked by OVX and restored by replacement of 17-beta-estradiol or, to a less extent, by replacement of progesterone. In addition, we also detected female hormone-associated changes in slow oscillation in VTA DA neurons. The results indicate that ovarian hormones, particularly estrogen, not only synergize with the inhibitory effect of cocaine on VTA DA neuron activity but also play an essential role in maintaining the sensitivity of DA neurons to cocaine-mediated inhibition on firing. Moreover, pretreatment of estrogen receptor (ER) antagonist raloxifene or a selective ERalpha antagonist Y134 largely attenuated the cocaine-inhibited DA neuron firing. We also found that cocaine-induced locomotor activity was estrous cycle dependent; 17-beta-estradiol but not progesterone replacement restored the cocaine-induced locomotor activity in OVX rats. CONCLUSION: The present results demonstrated that ovarian hormones, particularly estrogen, produce profound effect on VTA DA neuron activity, which, in turn, may contribute to the sex differences in response to psychostimulants.
RATIONALE: Sex differences in cocaine abuse have been well documented. However, the underlying mechanism remains unclear. OBJECTIVES: To explore the potential role of ovarian hormones in the regulation of dopamine (DA) neuron firing activity in ventral tegmental area (VTA) induced by acute cocaine in intact female or ovariectomized (OVX) rats. RESULTS: The basal firing activity of VTA DA neurons was changed in a manner phase-locked to the estrous cycle: being highest in estrus and lowest in proestrus. Acute cocaine produced greater inhibition (P < 0.05) on the firing of VTA DA neurons during proestrus than during estrus. The inhibitory effect was completely blocked by OVX and restored by replacement of 17-beta-estradiol or, to a less extent, by replacement of progesterone. In addition, we also detected female hormone-associated changes in slow oscillation in VTA DA neurons. The results indicate that ovarian hormones, particularly estrogen, not only synergize with the inhibitory effect of cocaine on VTA DA neuron activity but also play an essential role in maintaining the sensitivity of DA neurons to cocaine-mediated inhibition on firing. Moreover, pretreatment of estrogen receptor (ER) antagonist raloxifene or a selective ERalpha antagonist Y134 largely attenuated the cocaine-inhibited DA neuron firing. We also found that cocaine-induced locomotor activity was estrous cycle dependent; 17-beta-estradiol but not progesterone replacement restored the cocaine-induced locomotor activity in OVXrats. CONCLUSION: The present results demonstrated that ovarian hormones, particularly estrogen, produce profound effect on VTA DA neuron activity, which, in turn, may contribute to the sex differences in response to psychostimulants.
Authors: Kerry A Kerstetter; Maya A Ballis; Stevie Duffin-Lutgen; Amanda E Carr; Alexandra M Behrens; Tod E Kippin Journal: Neuropsychopharmacology Date: 2012-08-08 Impact factor: 7.853
Authors: Luyi Zhou; Carla Pruitt; Christina B Shin; Arturo D Garcia; Arturo R Zavala; Ronald E See Journal: Brain Struct Funct Date: 2013-07-06 Impact factor: 3.270
Authors: Amanda E D Van Swearingen; Cristina L Sanchez; Suzanne M Frisbee; Antonia Williams; Q David Walker; Kenneth S Korach; Cynthia M Kuhn Journal: Neuropharmacology Date: 2013-04-19 Impact factor: 5.250